|
2024
|
Invention
|
Beta-glucan immunotherapies affecting the immune microenvironment.
This disclosure relates to so... |
|
|
Invention
|
Beta-glucan in combination with anti-cancer agents affecting the tumor micrenvironment.
The pres... |
|
|
Invention
|
Beta-glucan methods and compositions that affect the tumor microenvironment.
This disclosure rel... |
|
|
Invention
|
N-isopropylnicotinamide and methods for using the same. Provided herein are crystalline forms of ... |
|
|
Invention
|
Crystalline forms of 6-(3-((5-chloro-2-methoxypyridine)-3- sulfonamido)-2,6-difluorophenyl)-n-met... |
|
2023
|
Invention
|
Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment.
The pre... |
|
|
Invention
|
Perk inhibitor hc-5404 in combination with anti-pd-1 antibody and/or an antiangiogenetic agent fo... |
|
|
Invention
|
Gcn2 inhibitor for treating metastases. Provided herein are methods of inhibiting myeloid-derived... |
|
|
Invention
|
Beta glucan immunopharmacodynamics.
This disclosure provides, in one aspect, dosing strategies f... |
|
|
Invention
|
Compositions and methods for treating type 1 diabetes. This disclosure relates to compositions an... |
|
|
Invention
|
Gcn2 modulator for treating cancer |
|
|
Invention
|
Gcn2 modulator for treating cancer. Provided herein are methods of treating advanced solid tumors... |
|
|
Invention
|
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors.
The invention rel... |
|
2022
|
Invention
|
Soluble β-glucans for inducing trained immunity. The present disclosure provides methods of treat... |
|
|
P/S
|
research and development of pharmaceuticals |
|
|
P/S
|
pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Gcn2 modulating compounds and uses thereof.
Provided herein are compounds, compositions, and met... |
|
|
Invention
|
Gcn2 modulating compounds and uses thereof. Provided herein are compounds, compositions, and meth... |
|
|
Invention
|
Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors. The invention re... |
|
2021
|
Invention
|
Methods for identifying beta-glucan binding to immune cells.
This disclosure describes, in one a... |
|
|
Invention
|
Perk inhibitors for treating viral infections. Provided herein are methods for treating a viral i... |
|
|
Invention
|
Perk inhibiting imidazolopyrazine compounds. Provided herein are methods for treating a viral inf... |
|
|
Invention
|
Perk inhibiting pyrrolopyrimidine compounds to treat viral infections. Provided herein are method... |
|
|
Invention
|
Heterocyclic gcn2 modulators. The invention relates to methods of using modulators of GCN2 and co... |
|
2020
|
Invention
|
Perk inhibiting pyrrolopyrimidine compounds.
Provided herein are compounds, compositions, and me... |
|
|
Invention
|
Perk inhibiting imidazolopyrazine compounds.
Provided herein are compounds, compositions, and me... |
|
|
Invention
|
Perk inhibiting indolinyl compounds.
Provided herein are compounds, compositions, and methods us... |
|
|
Invention
|
Perk inhibiting compounds.
Provided herein are compounds, compositions, and methods useful for i... |
|
|
Invention
|
Perk inhibiting imidazolopyrazine compounds. Provided herein are compounds of formula (I) as show... |
|
|
Invention
|
Perk inhibiting compounds. Provided herein are compounds of formula (I), compositions, and method... |
|
|
Invention
|
Perk inhibiting pyrrolopyrimidine compounds. Provided herein are compounds of formula (I), compos... |
|
|
Invention
|
Perk inhibiting indolinyl compounds. Provided herein are compounds of formula (I), compositions, ... |
|
|
Invention
|
Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors. The invention ... |
|
|
Invention
|
Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors.
The invention r... |
|
|
Invention
|
(aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical condition... |
|
2019
|
Invention
|
Beta glucan and cd40 agonist combination immunotherapy.
The present invention relates to the com... |
|
|
Invention
|
Beta glucan and cd40 agonist combination immunotherapy. The present invention relates to the comb... |
|
2018
|
Invention
|
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors. The invention rela... |
|
|
Invention
|
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors. The invention r... |
|
|
Invention
|
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors. The invent... |
|
|
Invention
|
Beta glucan immunopharmacodynamics. This disclosure provides, in one aspect, dosing strategies fo... |
